{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:00Z","timestamp":1787026380298,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progressive overloads of intrahepatic triglycerides are related to metabolic dysregulation of multiple lipid and lipoprotein profiles, but whether similar dose effects are found in each subtype of metabolic associated fatty liver disease (MAFLD) remains unclear. We aimed to characterize the lipid profiles associated with liver fat content (LFC) in MAFLD patients who were overweight, lean\/normal weight, or had diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study enrolling 1,182 consecutive participants (144 non-MAFLD and 1,038 MAFLD) who underwent MRI proton density fat fraction measurement (MRI-PDFF) from 2011 to 2020. Lipid and apolipoprotein profiles, free fatty acid (FFA), liver and metabolism parameters, and anthropometric measurements were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MAFLD patients with type 2 diabetes or overweight\/obesity had a higher proportion of abnormal lipid and lipoprotein profiles than those who were lean\/normal weight. The degree of LFC had a positive correlation with total cholesterol, triglyceride, ApoB, and ApoE in patients with overweight\/obesity and type 2 diabetes. In those with overweight\/obesity, there were dose\u2013response relationships between moderate-to-severe steatosis and total cholesterol, triglyceride, HDL-c, LDL-c, ApoB, ApoE, and Lp(a). A similar trend was observed for triglyceride in those with type 2 diabetes and for HDL-c in patients who were lean\/normal weight (all\n                      <jats:italic>p<\/jats:italic>\n                      for trend &amp;lt;0.05). The combined model of relative lipid-related markers performed well in the prediction of moderate-to-severe steatosis (AUC: 0.762 for overweight\/obesity; 0.742 for lean\/normal weight).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LFC was associated with lipid profiles, including triglyceride, LDL-c, ApoB, ApoE, and FFA. These relationships were varied by the phenotype of MAFLD according to its diagnostic flow.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.691556","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:20:15Z","timestamp":1638325215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Tingfeng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.005","article-title":"Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis","volume":"153","author":"Middleton","year":"2017","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines for the Diagnosis and Management of Metabolic Associated Fatty Liver Disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30432-1","article-title":"Prevalence of Obesity, Hypertension, and Diabetes, and Cascade of Care in Sub-Saharan Africa: A Cross-Sectional, Population-Based Study in Rural and Urban Malawi","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"Brunzell","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e111283","DOI":"10.1371\/journal.pone.0111283","article-title":"MR Quantification of Total Liver Fat in Patients With Impaired Glucose Tolerance and Healthy Subjects","volume":"9","author":"Dong","year":"2014","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.024","article-title":"Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients With Non-Alcoholic Steatohepatitis: Analysis of Data From a Phase II Trial of Selonsertib","volume":"70","author":"Jayakumar","year":"2019","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29639","article-title":"Optimal Threshold of Controlled Attenuation Parameter With MRI-PDFF as the Gold Standard for the Detection of Hepatic Steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.11.027","article-title":"Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique","volume":"13","author":"Lin","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28985","article-title":"Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19980730)17:14<1623::aid-sim871>3.0.co;2-s","article-title":"A Simple Method of Sample Size Calculation for Linear and Logistic Regression","volume":"17","author":"Hsieh","year":"1998","journal-title":"Stat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.02.019","article-title":"Different Predictors of Steatosis and Fibrosis Severity Among Lean, Overweight and Obese Patients With Nonalcoholic Fatty Liver Disease","volume":"51","author":"Shao","year":"2019","journal-title":"Dig Liver Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14597","article-title":"NAFLD is Related to Post-Prandial Triglyceride-Enrichment of HDL Particles in Association With Endothelial and HDL Dysfunction","volume":"40","author":"Verwer","year":"2020","journal-title":"Liver Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12944-019-0984-9","article-title":"Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio is a Significant Predictor of Nonalcoholic Fatty Liver: Jinchang Cohort Study","volume":"18","author":"Ren","year":"2019","journal-title":"Lipids Health Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","article-title":"Plasma Levels of Apolipoprotein E and Risk of Ischemic Heart Disease in the General Population","volume":"246","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13363","article-title":"Serum apoB Levels Independently Predict the Development of Non-Alcoholic Fatty Liver Disease: A 7-Year Prospective Study","volume":"37","author":"Wang","year":"2017","journal-title":"Liver Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic Fatty Liver Disease and Serum Lipoproteins: The Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1966","article-title":"High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2019.06.012","article-title":"Non-Invasive Assessment of Hepatic Lipid Subspecies Matched With non-Alcoholic Fatty Liver Disease Phenotype","volume":"29","author":"Erickson","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6289831","article-title":"Hepatic Fat Content and Liver Enzymes Are Associated With Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated With Low-Grade Inflammation: The CODAM Study","volume":"2019","author":"Bijnen","year":"2019","journal-title":"J Diabetes Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-020-01409-1","article-title":"Association Between Triglyceride Glucose-Body Mass Index and Non-Alcoholic Fatty Liver Disease in the Non-Obese Chinese Population With Normal Blood Lipid Levels: A Secondary Analysis Based on a Prospective Cohort Study","volume":"19","author":"Li","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.metabol.2017.04.004","article-title":"High Prevalence of Apolipoprotein B Dyslipoproteinemias in non-Alcoholic Fatty Liver Disease: The Lifelines Cohort Study","volume":"72","author":"Nass","year":"2017","journal-title":"Metabolism"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2011.328","article-title":"Effects of Insulin Resistance and Hepatic Lipid Accumulation on Hepatic mRNA Expression Levels of Apob, MTP and L-FABP in Non-Alcoholic Fatty Liver Disease","volume":"2","author":"Higuchi","year":"2011","journal-title":"Exp Ther Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological Activities of HDL Subpopulations and Their Relevance to Cardiovascular Disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","article-title":"Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes After Weight Loss","volume":"31","author":"Al-Mrabeh","year":"2020","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1775287","article-title":"Lipoprotein(a) in Atherosclerosis: From Pathophysiology to Clinical Relevance and Treatment Options","volume":"52","author":"Rehberger Likozar","year":"2020","journal-title":"Ann Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the Risk of Cardiovascular Disease in the European Population: Results From the BiomarCaRE Consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.07.020","article-title":"Serum Lipoprotein(a) Levels and Insulin Resistance Have Opposite Effects on Fatty Liver Disease","volume":"308","author":"Jung","year":"2020","journal-title":"Atherosclerosis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2020.02.026","article-title":"Advanced Fibrosis of non-Alcoholic Steatohepatitis Affects the Significance of Lipoprotein(a) as a Cardiovascular Risk Factor","volume":"299","author":"Konishi","year":"2020","journal-title":"Atherosclerosis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29359","article-title":"The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated With Specific Changes in Circulating Bile Acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i7.800","article-title":"Is the Control of Dietary Cholesterol Intake Sufficiently Effective to Ameliorate Nonalcoholic Fatty Liver Disease","volume":"16","author":"Enjoji","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of Large VLDL Particles Is Driven by Increased Liver Fat Content in Man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.691556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:20:17Z","timestamp":1638325217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.691556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":37,"alternative-id":["10.3389\/fendo.2021.691556"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.691556","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"article-number":"691556"}}